James Lindsay
0000-0003-3353-9590
Queen Mary University of London
7 papers found
Refreshing results…
Defining predictors of responsiveness to advanced therapies in Crohn’s disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine
Considerations for peripheral blood transport and storage during large-scale multicentre metabolome research
Prebiotic fructans have greater impact on luminal microbiology and CD3+ T cells in healthy siblings than patients with Crohn's disease: A pilot study investigating the potential for primary prevention of inflammatory bowel disease
Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator Infliximab
Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
Ulcerative Colitis: Shifting Sands
Missing publications? Search for publications with a matching author name.